西藥品
用藥查詢
西藥品查詢
外觀圖示:
外觀圖示

外觀描述:
棕色玻璃瓶

醫令代碼:
30529

商品名:
NIMOTOP INFUSION 50CC(注射)

中文名:
腦妥靜脈輸注液

學名:
Nimodipine 0.2mg/ml

劑型:
BOT

孕婦用藥分級:
C 級

健保碼:
BC18843248

藥品許可證:
衛署藥輸字第018843號

仿單下載:

用藥指導單張:

ATC7藥理類別:

結構式 :

isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m- nitrophenyl)-3,5–pyridinedicarboxylate


UpToDate:

藥理作用 :
(1)高親脂性鈣離子拮抗劑,對腦血管有優先的活性。(2)可顯著改善腦血循環,防止痙攣。(3)預防腦血管缺血,保護大腦細胞免於死亡。(4)本品也具有神經藥理(nuropharmacological)和精神藥理(psychopharmacological)的作用。

適應症:
預防、治療蜘蝌膜下出血後、腦血管痙攣所引起的缺血性神經缺損。

用法用量:
IV Form:體重70KG以下或血壓不足者開始治療時,前兩小時每小時0.5毫克的Nimodipine。體重70KG以上每小時1毫克Nimodipine的速度注射2小時,若無副作用則可加倍劑量繼續給予。Oral Form:注射10~14天後,建議口服Nimotop膜衣錠,每天6次,每次60毫克,約七天。

副作用:
頭痛,面部潮紅,胃部症狀,嘔心,灼熱感和血壓降低。

藥物動力學:

Absorption
Nimodipine is rapidly absorbed after oral administration. Bioavailability is 13% and Tmax is approximately 1 h. Food decreases peak plasma concentration 68% and bioavailability 38%.

Distribution
Nimodipine protein binding is over 95%.

Metabolism
Extensive first-pass metabolism in the liver.

Elimination
Nimodipine is eliminated in urine (less than 1% unchanged), and metabolites are considerably less active than parent compound. Terminal t1/2 is 8 to 9 h, and initial t1/2 is 1 to 2 h.

Special Populations
Elderly
AUC and C max were approximately 2–fold higher; this response is not considered important.

Hepatic Function Impairment
Nimodipine bioavailability is increased, C max almost doubles, and dosage adjustment is necessary in patients with hepatic cirrhosis.


交互作用:

Beta-blockers
May cause increased adverse reactions because of myocardial contractility or AV conduction depression.

Cimetidine, grapefruit juice
Nimodipine plasma levels may be elevated, increasing the pharmacologic effects and adverse reactions.

Fentanyl
May cause severe hypotension or increased fluid requirements.

Other hypertensive agents
May have additive effects.


禁忌:
懷孕期間,一般性腦血腫,顱內壓顯著增加者使用膜衣錠應特別小心。

注意事項:
(1)Nimotop IV不可直接加入注輸袋或注輸瓶中,應利用Y型管血旁邊注入正在滴注其他輸液之注輸管中。(2)Nimotop只能使用PE或PP的注輸管不可用PVC的注輸管。(3)Nimotop需配合Syringe Pump給予。

藥品保存方式:
藥品應置於攝氏 15 ~ 25 度乾燥處所;如發生變質或過期,不可再使用。

給付規定:
2.2.2. Nimodipine inj(如Nimotop):(87/4/1、93/2/1)
預防、治療因動膜瘤引起之蜘蛛膜下出血後,腦血管痙攣所引起的缺血性神經缺損,可使用二星期,需附電腦斷層掃描(CT Scan)報告。

Back to Top